Directorate Change

RNS Number : 7611B

Britvic plc

09 January 2015

 



Britvic plc

9 January 2015

DIRECTORATE CHANGE

Britvic plc today announces the appointment of John Daly as an Independent Non-Executive Director of the company.  This appointment will be effective from the conclusion of the company's Annual General Meeting, which will be held on Tuesday 27^th January 2015 at 11am. 

John is currently a Non-Executive Director of Wolseley plc, a position he has held since May 2014 and where he serves on the Audit, Remuneration and Nomination Committees.  Prior to this, John held various executive leadership positions over the course of 20 years at British American Tobacco plc. His most recent positions at BAT were Chief Operating Officer (from 2010 to 2014) and Regional Director for Asia Pacific, based in Hong Kong (from 2004 to 2010). John remains a Director of Reynolds American Inc., a US public company owned 42% by BAT. Prior to his time with BAT, John held various sales & marketing positions with Janssen Pharmaceuticals, Bristol-Myers Squibb, Pennwalt Corporation and Schering-Plough.

It is intended that John will become Senior Independent Director of the company and Chairman of the Remuneration Committee following the ultimate retirement from the board of Bob Ivell, who has held both positions since the company's flotation in 2005.

Commenting on the appointment Gerald Corbett, Chairman, said:

"We continue to evolve the Britvic board as we execute our strategy to drive growth in both our core markets and internationally.  John Daly has extensive international experience, combined with a deep understanding of global leadership in a number of sectors, and is well placed to add value to Britvic.  We are delighted to welcome him to the board."

John Daly said:

"I am looking forward to joining the Britvic board, and am excited at the prospect of working with Simon Litherland and his team as the business enters the next phase of its progression and continues to implement its strategic plan."

No further details remain to be disclosed for the above appointment as required under Rule 9.6.13 of the Listing Rules.

Clare Thomas

Company Secretary

For further information please contact:

Investors:
Rupen Shah (PLC Finance and Investor Relations Director)	[phone]
Steve Nightingale (Senior Investor Relations Manager)	[phone]
Media:
Susan Turner (Director of Corporate Affairs)	[phone]
Ben Foster (Pendomer Communications)	[phone]

 

END

 

 

BOAEANFNEDESEEF